Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Investor's Business DailyProtagonist Therapeutics is poised to join the S&P SmallCap 600 next Wednesday, replacing copper and aluminum wire manufacturer Encore Wire.
The post Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600 appeared first on Investor…